Inventors at the National Cancer Institute (NCI) have created a tool for developing new targeted therapies or enhancing patient stratification in transcriptomic multi-arm trials. This tool, named SELECT, uses a computational, precision-oncology framework that uses the tumor’s whole transcriptome to

Are you interested in licensing an automated digital pathology device? The National Cancer Institute (NCI) is seeking licensees to develop an automated digital pathology device that could be used for biopsy sample processing and applicable to diagnoses of various disease indications, including

The NIH Technology Transfer Community is made up of a wide variety of dedicated professionals. OTT would like to highlight and give special thanks to a few of them. Karen Rogers was the Acting Director of OTT from 2015-2020. This past year she won an Office of the Director award for her outstanding